Regulatory T (Treg) cells play key roles in various immune responses. For example, Treg cells contribute to the complex pathogenesis of inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis during onset or development of that disease. Many animal models of IBD have been used to investigate factors such as pathogenic cytokines, pathogenic bacteria, and T-cell functions, including those of Treg cells. In addition, analyses of patients with IBD facilitate our understanding of the precise mechanism of IBD. This review article focuses on the role of Treg cells and outlines the pathogenesis and therapeutic strategies of IBD based on previous reports
Background: FOXP3+ regulatory T cells (Tregs) are critical for preventing intestinal inflammation. H...
Triggering receptor expressed on myeloid cell-1 (TREM-1) signaling is expressed on neutrophils and m...
This work was funded by grants to M.J.W. from the Swedish Cancer Society [CAN2015/463 and CAN 2018/3...
Abstract: Regulatory CD4+ T (Treg) cells are comprised of a heterogeneous population of cells that p...
Crohn’s disease and ulcerative colitis, two major forms of inflammatory bowel disease (IBD) in human...
Crohn's disease and ulcerative colitis, the 2 major forms of inflammatory bowel disease (IBD) in hum...
The gastrointestinal tract is a site of high immune challenge, as it must maintain a delicate balanc...
Inflammatory bowel disease (IBD) is becoming more common in the Western world due to changes in diet...
Inflammatory bowel disease (IBD) is a chronic, inflammatory, and autoimmune disorder. The pathogenes...
FOXP3+ regulatory T cells (Treg cells) are a specialized population of CD4+ T cells that restrict im...
Inflammatory bowel disease (including Crohn’s disease and ulcerative colitis) and coeliac disease ar...
Background: Inflammatory bowel disease (IBD) is thought to result from an aberrant immune response. ...
The Triggering Receptors Expressed on Myeloid cells (TREM) are a family of cell-surface molecules th...
In normal conditions gut homeostasis is maintained by the suppressive activity of regulatory T cells...
Because of their potent suppressive capacity and critical role in the normal function of the human i...
Background: FOXP3+ regulatory T cells (Tregs) are critical for preventing intestinal inflammation. H...
Triggering receptor expressed on myeloid cell-1 (TREM-1) signaling is expressed on neutrophils and m...
This work was funded by grants to M.J.W. from the Swedish Cancer Society [CAN2015/463 and CAN 2018/3...
Abstract: Regulatory CD4+ T (Treg) cells are comprised of a heterogeneous population of cells that p...
Crohn’s disease and ulcerative colitis, two major forms of inflammatory bowel disease (IBD) in human...
Crohn's disease and ulcerative colitis, the 2 major forms of inflammatory bowel disease (IBD) in hum...
The gastrointestinal tract is a site of high immune challenge, as it must maintain a delicate balanc...
Inflammatory bowel disease (IBD) is becoming more common in the Western world due to changes in diet...
Inflammatory bowel disease (IBD) is a chronic, inflammatory, and autoimmune disorder. The pathogenes...
FOXP3+ regulatory T cells (Treg cells) are a specialized population of CD4+ T cells that restrict im...
Inflammatory bowel disease (including Crohn’s disease and ulcerative colitis) and coeliac disease ar...
Background: Inflammatory bowel disease (IBD) is thought to result from an aberrant immune response. ...
The Triggering Receptors Expressed on Myeloid cells (TREM) are a family of cell-surface molecules th...
In normal conditions gut homeostasis is maintained by the suppressive activity of regulatory T cells...
Because of their potent suppressive capacity and critical role in the normal function of the human i...
Background: FOXP3+ regulatory T cells (Tregs) are critical for preventing intestinal inflammation. H...
Triggering receptor expressed on myeloid cell-1 (TREM-1) signaling is expressed on neutrophils and m...
This work was funded by grants to M.J.W. from the Swedish Cancer Society [CAN2015/463 and CAN 2018/3...